How Should Canadian Pharmacy Departments Utilize Idarucizumab?
作者信息
Tangedal Kirsten, Semchuk William, Bolt Jennifer
机构信息
Department of Pharmacy Services Regina Qu'Appelle Health Region Regina, Saskatchewan.
出版信息
Can J Hosp Pharm. 2016 Sep-Oct;69(5):429-430. doi: 10.4212/cjhp.v69i5.1601. Epub 2016 Oct 31.
Abstract
摘要
相似文献
1
How Should Canadian Pharmacy Departments Utilize Idarucizumab?加拿大药房部门应如何使用依达赛珠单抗？
Can J Hosp Pharm. 2016 Sep-Oct;69(5):429-430. doi: 10.4212/cjhp.v69i5.1601. Epub 2016 Oct 31.
2
Idarucizumab administration for reversing dabigatran effect in an acute kidney injured patient with bleeding.使用依达赛珠单抗逆转急性肾损伤出血患者的达比加群效应。
Thromb Haemost. 2017 Jan 5;117(1):196-197. doi: 10.1160/TH16-06-0445. Epub 2016 Oct 13.
3
[Dabigatran specific antidote: new safety level in oral anticoagulation].
MMW Fortschr Med. 2015 Nov 5;157(19):78-9.
4
Idarucizumab: The Antidote for Reversal of Dabigatran.艾达司珠单抗：达比加群逆转的解毒剂。
Circulation. 2015 Dec 22;132(25):2412-22. doi: 10.1161/CIRCULATIONAHA.115.019628.
5
Anticoagulants: Updates on idarucizumab.抗凝剂：艾达赛珠单抗的最新进展。
Br Dent J. 2017 Feb 10;222(3):140-141. doi: 10.1038/sj.bdj.2017.95.
6
[Safer in everyday clinical care].
MMW Fortschr Med. 2015 Nov 5;157(19):79.
7
Idarucizumab for Dabigatran Reversal Guideline.
Crit Pathw Cardiol. 2016 Jun;15(2):33-5. doi: 10.1097/HPC.0000000000000074.
8
Idarucizumab: First Global Approval.依达鲁珠单抗：全球首次获批
Drugs. 2015 Dec;75(18):2155-61. doi: 10.1007/s40265-015-0508-5.
9
Idarucizumab for dabigatran overdose in a child.依达赛珠单抗用于儿童达比加群过量
Br J Haematol. 2018 Feb;180(3):457-459. doi: 10.1111/bjh.14371. Epub 2016 Oct 13.
10
Real-World Experience with Idarucizumab to Reverse Anticoagulant Effect in Dabigatran-Treated Patients: Report of 11 Cases from Taiwan.依达赛珠单抗逆转达比加群治疗患者抗凝作用的真实世界经验：来自台湾的11例报告
J Stroke Cerebrovasc Dis. 2018 Feb;27(2):e27-e33. doi: 10.1016/j.jstrokecerebrovasdis.2017.09.044. Epub 2017 Nov 6.
引用本文的文献
1
Extended Sulfo-Pillar[6]arenes ─ a New Host Family and Its Application in the Binding of Direct Oral Anticoagulants.扩展磺化柱[6]芳烃——一种新型主体家族及其在直接口服抗凝剂结合中的应用
J Am Chem Soc. 2024 Oct 2;146(41):28005-13. doi: 10.1021/jacs.4c03905.
本文引用的文献
1
Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity.依达赛珠单抗用于逆转 Xa 因子抑制剂的活性。
N Engl J Med. 2015 Dec 17;373(25):2413-24. doi: 10.1056/NEJMoa1510991. Epub 2015 Nov 11.
2
Idarucizumab for Dabigatran Reversal.达比加群酯逆转剂依达鲁珠单抗。
N Engl J Med. 2015 Aug 6;373(6):511-20. doi: 10.1056/NEJMoa1502000. Epub 2015 Jun 22.
3
Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial.达比加群酯逆转剂依达鲁珠单抗在健康男性志愿者中的安全性、耐受性和疗效：一项随机、安慰剂对照、双盲的 1 期临床试验。
Lancet. 2015 Aug 15;386(9994):680-90. doi: 10.1016/S0140-6736(15)60732-2. Epub 2015 Jun 15.
4
The impact of bleeding complications in patients receiving target-specific oral anticoagulants: a systematic review and meta-analysis.目标特异性口服抗凝剂治疗患者出血并发症的影响：系统评价和荟萃分析。
Blood. 2014 Oct 9;124(15):2450-8. doi: 10.1182/blood-2014-07-590323. Epub 2014 Aug 22.
5
Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry.在心房颤动患者中同时使用阿司匹林治疗和口服抗凝治疗的情况及相关风险：来自 Outcomes Registry for Better Informed Treatment of Atrial Fibrillation（ORBIT-AF）登记研究的见解。
Circulation. 2013 Aug 13;128(7):721-8. doi: 10.1161/CIRCULATIONAHA.113.002927. Epub 2013 Jul 16.
6
Assessment of anticoagulation intensity and management of bleeding with old and new oral anticoagulants.新旧口服抗凝剂的抗凝强度评估和出血管理。
Can J Cardiol. 2013 Jul;29(7 Suppl):S34-44. doi: 10.1016/j.cjca.2013.04.013.
7
A specific antidote for dabigatran: functional and structural characterization.达比加群的特效解毒剂：功能和结构特征。
Blood. 2013 May 2;121(18):3554-62. doi: 10.1182/blood-2012-11-468207. Epub 2013 Mar 8.
8
Bleeding risk and the management of bleeding complications in patients undergoing anticoagulant therapy: focus on new anticoagulant agents.接受抗凝治疗患者的出血风险及出血并发症的管理：聚焦新型抗凝药物
Blood. 2008 May 15;111(10):4871-9. doi: 10.1182/blood-2007-10-120543. Epub 2008 Feb 28.
Zotero 插件